Last reviewed · How we verify
NCT03867604
Ultrasound-guided Fascial Release Injection for Myofascial Pain Syndrome in the Upper Trapezius Muscle
NA trial testing Sham injection in Myofascial Pain Syndrome in 20 participants. Completed in 1 December 2022.
1 June 2022
Quick facts
| Lead sponsor | Taipei Medical University WanFang Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 June 2019 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Sham injection — full drug profile →
- Fascia injection
Conditions studied
- Myofascial Pain Syndrome — all drugs for Myofascial Pain Syndrome →
Sponsor
Taipei Medical University WanFang Hospital
Who can join
Adults 20 to 70, any sex, with Myofascial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with myofascial pain syndrome at upper trapezius will be randomized into 2 groups, fascial injection group and subcutaneous control injection group. Pain condition pain, range of motion and function will be evaluated in 1 week, 4 weeks and 12 weeks after injection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03867604
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sham injection
Trials testing the same drug.
- NCT07282457 — Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Th · Phase 1, PHASE2 · not yet recruiting
- NCT06999057 — Quadriceps Motor Unit Adaptation to Simulated Knee Injury · NA · not yet recruiting
- NCT06270836 — A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Dia · Phase 3 · active not recruiting
- NCT07174167 — Genicular Nerve Block in Chronic Knee Osteoarthritis · NA · completed
- NCT05587205 — Safety and Tolerability of EO2002 · Phase 1 · recruiting
Other recruiting trials for Myofascial Pain Syndrome
Currently open trials in the same condition.
- NCT07511751 — COMPARISON OF THREE TREATMENT MODALITIES İN MYOFASCIAL PAIN SYNDROME · NA · recruiting
- NCT07045324 — Effect of Vagus Nerve Stimulation on Trapezius Trigger Point · NA · active not recruiting
Other Taipei Medical University WanFang Hospital trials
Trials by the same sponsor.
- NCT07401017 — The Effects of Rosuvastatin on Running Training Adaptation and Safety · NA · not yet recruiting
- NCT07293442 — Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. · NA · recruiting
- NCT07150182 — Shared Decision-Making for Families in Critical Dialysis Initiation · NA · not yet recruiting
- NCT06834425 — Efficacy of NSAID Peritendinous Injection for Acute Tendinitis · NA · active not recruiting
- NCT06862297 — Prospective Study Between Polysomnography (PSG) and Novel Ultrasonic Jaw Tracking Device in Patients with Sleep Apnea · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03867604 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University WanFang Hospital
- Last refreshed: 13 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03867604.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing